Chris McFarlane is an experienced professional currently serving as Manager Innovation and Program Lead Innovation at South32 since February 2022, while also working as a Consultant independently. Prior to these roles, Chris was the Vice President of Strategy & Operations at PYC Therapeutics, contributing to the development of RNA-based therapies for genetic diseases. Chris's career includes significant experience at Bain & Company, where the focus was on strategy, large-scale transformations, and performance improvement, with oversight of over 30 consultants. Earlier work involved research and engineering roles at The University of Western Australia and internships at Chevron and Rio Tinto. Chris holds a Bachelor of Engineering with First Class Honours in Mechanical Engineering and a Bachelor of Science with a double major in Physics and Applied Mathematics from The University of Western Australia.
This person is not in any teams
This person is not in any offices